Key result
Adverse drug reaction surveillance and reporting to the FDA's MedWatch program aim to heighten awareness and promote the prevention of specific medication-related harms.
Key points are not available for this paper at this time.
Design
Editorial
This feature highlights various adverse drug reactions to promote awareness and reporting to the FDA's MedWatch program.
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
No takes yet. Share an insight, caveat, or question.
Joel Shuster (2005) studied this question. Adverse drug reaction surveillance and reporting to the FDA's MedWatch program aim to heighten awareness and promote the prevention of specific medication-related harms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: